GlobalData’s new report, “Sanofi-Aventis Market Share Analysis” provides in-depth information on Sanofi’s market position in the different medical equipment markets it operates in.

Dallas, TX -- (SBWire) -- 12/08/2010 -- SandlerResearch announce Sanofi-Aventis Market Share Analysis

Original Source : Sanofi Aventis Market
http://www.sandlerresearch.org/reports/37897-sanofi-aventis-market-share-analysis.html

Buy Now : Market Research
http://www.sandlerresearch.org/

Browse complete Report at : Sanofi-Aventis Market Share Analysis
http://www.sandlerresearch.org/reports/37897-sanofi-aventis-market-share-analysis.html

Sanofi-Aventis Market Share Analysis

GlobalData’s new report, “Sanofi-Aventis Market Share Analysis” provides in-depth information on Sanofi’s market position in the different medical equipment markets it operates in. The report provides Sanofi’s market share information in one key market category – Insulin Delivery. The report also provides data and information on the overall competitive landscape of the markets, the company operates in. The report is supplemented with global corporate-level profile with information on the company’s business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

Global company shares (in Revenues) information for the key markets Sanofi operates in – Diabetes Care Devices.
Sanofi’s company shares (in Revenues) information for all the key countries the company has presence in – United States, Canada, UK, Germany, France, Italy, Spain, Japan, China, India, and Australia.
Sanofi’s company shares (in Revenues) information for all the key market category the company has presence in – Insulin Delivery
All the key data-points are for 2009 and cover all the key regions – North America, Europe, Asia Pacific (APAC), and Middle East and Africa (MEA).
Global corporate-level profile with information on the company’s business segments, major products and services, competitors, and locations and subsidiaries.
The company profile is also supplemented with a SWOT Analysis with in-depth information and analysis of the company’s value proposition and the business climate it operates in.
Comprehensive coverage of the latest financial deals involving the company and its subsidiaries, if any – Mergers & Acquisitions (M&A), Asset Transactions, PE/VC, Equity Offerings, Debt Offerings, and Partnerships.

Reasons to buy

Develop sales and marketing strategies by identifying who-stands-where in the markets, Sanofi operates in.
Plan your competition strategies by identifying the company’s shares in the markets and geographic regions it operates in.
Design your own inorganic growth and business-collaboration strategies by understanding the financial deals your competitors are involved in.
Advance your understanding of the competitive landscape and the competitors by leveraging on the data and information provided in the report.
Support your overall business strategies by leveraging on the key data and information provided in the report, which includes but not limited to Sanofi’s market positions.

1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 9
2 Introduction 10
2.1 What Is This Report About? 10
3 Definitions of Markets/Categories Covered 11
3.1 Diabetes Care Devices 11
3.1.1 Glucose Monitoring 11
3.1.2 Insulin Delivery 11
4 Company Snapshot 12
4.1 Key Information 12
4.2 Company Overview 12
4.3 Financial Performance 12
4.4 SWOT Snapshot 12
4.5 Business Overview 13
4.6 Major Products and Services 15
4.6.1 Overview 15
5 History 16
6 SWOT Analysis 21
6.1 Overview 21
6.2 Sanofi-Aventis Strengths 22
6.2.1 Global Presence 22
6.2.2 Market Leadership in Vaccines 22
6.2.3 Strong Research and Development Activities 22
6.2.4 Acquisitions 23
6.2.5 Broad Product Portfolio 23
6.3 Sanofi-Aventis Weaknesses 23
6.3.1 Declining Operating Margin 23
6.3.2 Discontinuation of Late Phase Projects 23
6.3.3 Reliance on Third Parties 23
6.4 Sanofi-Aventis Opportunities 24
6.4.1 Product Approvals and Launches 24
6.4.2 Strategic Agreements 24
6.4.3 Focus on Biologics 24
6.4.4 Potential Diabetes Market 25
6.5 Sanofi-Aventis Threats 25
6.5.1 Intense Generic Competition 25
6.5.2 Pricing Pressures 25
6.5.3 Tightening of the FDA’s Regulatory Oversight 25
7 Competitors 26
8 Competitive Landscape 27
8.1 Diabetes Care Devices, Global, Company Share (%), 2009 27
9 Sanofi-Aventis Medical Equipment Market Share Analysis 29
9.1 Sanofi-Aventis, Diabetes Care Devices, Global, Market Share (2009) 29
9.2 Sanofi-Aventis, Asia-Pacific, Market Share (2009) 30
9.3 Sanofi-Aventis, Europe, Market Share (2009) 31
9.4 Sanofi-Aventis, Middle East and Africa, Market Share (2009) 32
9.5 Sanofi-Aventis, North America, Market Share (2009) 33
9.6 Sanofi-Aventis, South and Central America, Market Share (2009) 34
10 Sanofi-Aventis Medical Equipment Market Share Analysis by Category 35
10.1 Sanofi-Aventis, Diabetes Care Devices, Global, Category Revenue Share (2009) 35
10.2 Sanofi-Aventis, Asia-Pacific, Category Revenue Share (2009) 36
10.2.1 Sanofi-Aventis, Australia, Category Revenue Share (2009) 36
10.2.2 Sanofi-Aventis, China, Category Revenue Share (2009) 36
10.2.3 Sanofi-Aventis, India, Category Revenue Share (2009) 37
10.2.4 Sanofi-Aventis, Japan, Category Revenue Share (2009) 37
10.2.5 Sanofi-Aventis, Other Asia-Pacific, Category Revenue Share (2009) 37
10.3 Sanofi-Aventis, Europe, Category Revenue Share (2009) 38
10.3.1 Sanofi-Aventis, France, Category Revenue Share (2009) 38
10.3.2 Sanofi-Aventis, Germany, Category Revenue Share (2009) 38
10.3.3 Sanofi-Aventis, Italy, Category Revenue Share (2009) 39
10.3.4 Sanofi-Aventis, Spain, Category Revenue Share (2009) 39
10.3.5 Sanofi-Aventis, United Kingdom, Category Revenue Share (2009) 39
10.3.6 Sanofi-Aventis, Other Europe, Category Revenue Share (2009) 40
10.4 Sanofi-Aventis, Middle East and Africa, Category Revenue Share (2009) 41
10.5 Sanofi-Aventis, North America, Category Revenue Share (2009) 42
10.5.1 Sanofi-Aventis, Canada, Category Revenue Share (2009) 42
10.5.2 Sanofi-Aventis, United States, Category Revenue Share (2009) 42
10.6 Sanofi-Aventis, South and Central America, Category Revenue Share (2009) 43
10.6.1 Sanofi-Aventis, Brazil, Category Revenue Share (2009) 43
10.6.2 Sanofi-Aventis, Other South and Central America, Category Revenue Share (2009) 43
11 Share Holding Structure 44
12 Key Employees 45
13 Key Employee Biographies 46
14 Company Statement 48
15 Locations And Subsidiaries 49
15.1 Head Office 49
15.2 Other Locations & Subsidiaries 49
16 Financial Deals Landscape 53
16.1 Sanofi-Aventis, Deals Volume Summary, 2005 to YTD 2010 53
17 Sanofi-Aventis Detailed Deal Summary 55
17.1 Asset Purchase 55
17.1.1 Sanofi-Aventis Acquires Inhalation Assets From Siegfried 55
17.2 Private Equity 56
17.2.1 Osiris Therapeutics Secures $69 Million In Equity Financing 56
17.3 Partnerships 57
17.3.1 AgaMatrix Enters Signs Agreement With Sanofi-Aventis 57
17.3.2 Unilife Enters Into An Agreement With Sanofi Winthrop Industrie 58
17.3.3 Osiris Therapeutics Enters Into Agreement With Blackstone Medical 59
17.3.4 Unilife Medical Solutions Signs An Agreement With Sanofi-Aventis 60
17.3.5 Becton, Dickinson and Company Forms Partnership With Sanofi Pasteur 61
17.4 Equity Offering 62
17.4.1 Osiris Therapeutics Completes Private Placement Of $12 Million 62
17.4.2 Osiris Therapeutics Completes Private Placement Of $20 Million 63
17.4.3 Osiris Completes Initial Public Offering Of $38.5 Million 64
17.4.4 Osiris Therapeutics Completes Private Placement Of $18.89 Million 65
17.4.5 Osiris Therapeutics Completes Private Placement Of $6.43 Million 66
17.4.6 Osiris Therapeutics Completes Private Placement Of $2.47 Million 67
17.5 Divestiture - Assets 68
17.5.1 NuVasive Acquires Osteocel Business From Osiris Therapeutics 68
17.5.2 Osiris Therapeutics Completes Private Placement Of Convertible Debt For $20 Million 70

ABBREVIATIONS

Browse all : Medical Devices
http://www.sandlerresearch.org/market-research/medical-devices/

Browse all : GlobalData Market
http://www.sandlerresearch.org/publishers/globaldata/

Browse all : Newly Published
http://www.sandlerresearch.org/LatestReport.aspx

Related Reports :

Sanofi-Aventis SA - SWOT Analysis
http://www.sandlerresearch.org/reports/2136-sanofi-aventis-sa-swot-analysis.html

Sanofi-Aventis: PharmaVitae Profile
http://www.sandlerresearch.org/reports/8051-sanofi-aventis-pharmavitae-profile.html

sanofi-aventis K.K.-Detailed Product Pipeline
http://www.sandlerresearch.org/reports/30688-sanofi-aventis-kk-detailed-product-pipeline.html

Sanofi-aventis-Deals & Alliances Report
http://www.sandlerresearch.org/reports/31737-sanofi-aventis-deals-alliances-report.html

Sanofi-aventis-Detailed Product Pipeline
http://www.sandlerresearch.org/reports/30689-sanofi-aventis-detailed-product-pipeline.html

About Us
Sandler Research houses a comprehensive online library of more than 10,000 reports, in-depth market research studies of 5000+ micro markets, and 25 industry specific websites. The reports are analytically and statistically rich, and offer a comprehensive view of the dynamic market scenario across the globe.
Our client list boasts of many eminent publishers of such reports from across the world. As a third-party reseller of market research reports, we employ various marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques, in order to generate better revenues for our clients, entailing positive and robust results.
We also provide 24/7 online and offline support to our customers

Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Website: http://www.sandlerresearch.org
Blog: http://sandlerresearch.blogspot.com